Table 1.
Association of antiretroviral therapy (ART) initiation guidelines with population‐level access to ART among people diagnosed with HIV infection
| Percentage of people diagnosed with HIV infection on ART | ||
|---|---|---|
| Model 1 | Model 2 | |
| ART initiation guidelines | ||
| Initiation at CD4 count ≤ 350 cells/μL | Reference | Reference |
| Initiation at CD4 count ≤ 500 cells/μL | −2.65 (−19.1 to 13.8) | 0.23 (−13.3 to 13.8) |
| Initiation at any CD4 count (test‐and‐treat) | 20.8* (5.20–36.4) | 15.2* (0.82–29.6) |
| Per 1% increase in GDP per capita (≈$927) | 1.58 (−7.89 to 11.1) | |
| Per $1000 increase in health care expenditure per capita | 6.55* (1.61–11.5) | |
| Per 1 SD increase in HIV prevalence (SD = 0.17%) | −4.77 (−10.6 to 1.03) | |
| Region | ||
| EU/EEA | Reference | |
| Eastern Europe and Central Asia | 3.04 (−14.7 to 20.8) | |
| Number of countries | 37 | 37 |
| R 2 | 0.319 | 0.626 |
A constant was included in all models but is not shown. 95% confidence intervals are shown in brackets. Model 1: unadjusted; model 2: adjusted for level of economic development, HIV prevalence, subregion and public health care expenditure.
EU/EEA, European Union and European Economic Area; SD, standard deviation.
*P < 0.05.